1. Introduction {#s0005}
===============

Syncope due to paroxysmal atrioventricular block (AVB) occurs because of a sudden change from apparently physiological atrioventricular conduction to transient second- or third-degree heart block, which leads to ventricular asystole.

Syncope is the main accompanying symptom in approximately 40% patients affected by recent-onset persistent AVB [@bib1], [@bib2], [@bib3]. However, the prevalence of syncope due to paroxysmal AVB is probably under-reported [@bib4]. In recent years, newly available long-term ECG monitoring devices have increased the diagnostic yield [@bib5], [@bib6].

2. Types of paroxysmal AV block {#s0010}
===============================

Three types of paroxysmal AVB are currently described in literature:•*Intrinsic paroxysmal atrioventricular block (I-AVB)* is due to an intrinsic disease of the AV conduction system; this type of "cardiac syncope," is also called Stokes-Adams attack.•*Extrinsic vagal paroxysmal atrioventricular block (EV-AVB)* is linked to parasympathetic influence on cardiac conduction and is one of the mechanisms involved in "reflex syncope."•*Extrinsic idiopathic paroxysmal atrioventricular block* (EI-AVB) is associated with low values of endogenous adenosine and is supposed to be one of the mechanisms involved in "low adenosine syncope."

The management (diagnosis and therapy) of patients with syncope suspected of being due to paroxysmal AVB depends on the type of block.

The distinguishing features of the three forms of paroxysmal AVB are summarized in [Table 1](#t0005){ref-type="table"} and [Fig. 1](#f0005){ref-type="fig"}.Fig. 1Continuous tracing shows an episode of intrinsic AVB (I-AVB) due to His-Purkinje conduction disease. AVB starts suddenly and ends with a ventricular premature beat; P-P cycle length remains constant throughout the recording. AVB=atrioventricular block.Fig. 1.Table 1Comparison of the 3 forms of paroxysmal AVB.Table 1Features**Intrinsic AV block (I-AVB)Extrinsic vagal AV block (EV-AVB)Extrinsic idiopathic AV block (EI-AVB)*****Cardiac syncope****Reflex syncope****adenosine syncope*****ECG**Sinus rhythmBBB frequentBBB infrequentNarrow QRSBefore AVB--Sometimes AVB initiated by APB or VPB--PR unchanged--Progressive sinus rate slowing (P-P cycle increase)--Generally progressive PR prolongation--Sinus rate unchanged (P-P cycle unchanged)--PR unchangedDuring asystolic AVBSinus rate increaseSinus rate slowingSinus rate unchanged(P-P cycle decrease)(P-P cycle increase)(P-P cycle unchanged)End of AVB--Sometimes AVB interrupted by APB or VPBSinus rate acceleration (P-P cycle decrease)Sinus rate unchanged (P-P cycle unchanged)Follow-upProgression to persistent AVBNo progression to persistent AVBNo progression to persistent AVB**Syncope**History of syncopeShort (mostly\<1 year)Long (since youth)Short (average 2 years)ProdromesNo or very short (≤5 s) prodromesAlways present \>10 sNo or very short (≤5 s) prodromesStructural heart diseaseMostly presentMostly absentAbsentAge on presentationElderlyAny ageAny age, mostly over 40 yearsEfficacy of pacemaker therapyEffectivePartially effectiveEffectiveEfficacy of theophylline therapyIneffectivePartially effectiveEffective**Investigations**Plasma adenosine valueNormalHighLow or very lowAdenosine (ATP) testUsually negativeMay be positiveFrequently positive (asystolic 3rd degree block)Tilt table testUsually negativeMostly positiveMostly negativeElectrophysiological studyFrequently positiveNegativeNegativeCarotid sinus massageUsually negativeFrequently positiveNegative[^1]

I-AVB is a manifestation of an intrinsic disease of the atrioventricular conduction system. It usually occurs in patients older than 60 years and is associated with bundle branch block (BBB) and/or an underlying heart disease [@bib4], [@bib7]. A short history of syncope is usually reported, the onset of syncopal episodes typically occurring within 1 year before the ECG diagnosis. I-AVB is characterized by progression toward permanent AVB [@bib2], [@bib4], [@bib7]. Electrocardiographically, this block starts mostly with an extrasystole, and the frequency of sinus node stimulation may be increased (tachy-dependent AVB) or decreased (brady-dependent AVB) **(**[Fig. 1](#f0005){ref-type="fig"}**).** The sudden onset of AVB explains why prodromes are absent or shorter than 5 s [@bib8].

EV-AVB is typically associated with well-identifiable triggers (central, i.e. emotional distress, or peripheral, i.e. prolonged standing) and characteristic symptoms of autonomic activation (i.e. feeling of warmth, an odd sensation in the abdomen, and lightheadedness or dizziness, nausea, and sweating) [@bib9]. Electrocardiographically, it is associated with two vagal effects on the conduction system: a gradual slowing of the sinus rate (P-P interval) and a delayed atrioventricular conduction (PR prolonging, or Wenckeback) followed by sinus arrest or complete AVB [@bib4], [@bib10], [@bib11], [@bib12] **(**[Fig. 2](#f0010){ref-type="fig"}**).** Consequently, prodromes are much longer than those in I-AVB [@bib13]. A long history of syncope, with onset in young middle age, is usually reported. EV-AVB does not progress to stable AVB because it is not an expression of anatomical involvement of the atrioventricular conduction system [@bib14].Fig. 2Continuous tracing shows an episode of extrinsic vagal paroxysmal AV block (EV-AVB). A gradual slowing of the sinus rate (P-P interval) before and during the asystolic pause and a delay of AV conduction (prolonging PR) followed by complete AV block is typical of vagal origin. AV=atrioventricular.Fig. 2.

The clinical observation of clinical and electrophysiological features in some patients with AVB that are different from those with the two above-mentioned forms of block has led to the identification of a third distinct clinical entity. EI-AVB is characterized by a long-standing history of recurrent syncope without prodromes and is associated with normal heart and normal electrocardiogram [@bib15]; additionally, EI-AVB does not progress to persistent forms [@bib16]. In such clinical conditions, an abrupt-onset AVB without significant rhythm disturbances before or during the attack (type IC block according to ISSUE classification) is pathognomonic **(**[Fig. 3](#f0015){ref-type="fig"}**).** The sudden onset of the AVB explains why prodromes are absent or shorter than 5 s. Typically, EI-AVB is associated with low baseline adenosine plasma levels and shows a high susceptibility to exogenous adenosine. EI-AVB has been found in 8% patients with syncope and normal ECG but without structural heart disease (corresponding to 15% of those with ECG documentation of syncope) [@bib17].Fig. 3Continuous Holter tracing shows two episodes of extrinsic idiopathic paroxysmal AV block (EI-AVB) that occurred a few minutes apart. The two episodes were very similar and were characterized by sudden-onset complete AV block without changes in the P-P cycle length, which constantly remained 720 ms (top, trace), and long ventricular asystoles of 7 and 11 s, respectively (bottom, compressed trace). *From Ref*[@bib16]*, with permission.* AV=atrioventricular.Fig. 3.

No single symptom or sign is diagnostic for a specific type of AVB. An intrinsic AVB is more likely in patients with baseline BBB, although the presence of BBB does not rule out an EV-AVB; indeed, \> 40% patients with BBB have reflex syncope, and in another 15%, the cause of syncope remains unknown [@bib18]. Differential diagnosis may be difficult in cases with slight increases in PP intervals, which is consistent with sinus arrhythmia. According to some authors [@bib19], [@bib20], an increase in this interval of only 40 ms suggests that the block is of vagal origin. This value of 40 ms is arbitrary, and a much more evident slowing of the sinus rate should probably be documented [@bib14]. The coexistence of two types of AVB mechanisms, i.e. vagal and adenosine, may be observed **(**[Fig. 4](#f0020){ref-type="fig"}**).** Absent or short prodromes are common to both I-AVB [@bib8] and EI-AVB [@bib16], whereas in patients without structural heart disease, prodromes lasting more than 10 s are associated with reflex syncope [@bib13]. Moreover, it is well known that the perception of symptoms varies from patient to patient and that a phenomenon of retrograde amnesia frequently occurs in patients with syncope [@bib9]. \"High-risk\" features that suggest a diagnosis of I-AVB are the presence of a definite structural heart disease, and syncope during exertion, or while lying in supine position, or preceded by sudden-onset palpitations. \"Low-risk\" features, which suggest EV-AVB, are the absence of heart disease, a long-standing history of recurrent syncope, the occurrence of syncope after exertion or after prolonged standing or in crowded places, during a meal, on head rotation or pressure on the carotid sinus, or after a sudden unexpected pain, unpleasant sight, sound, or smell [@bib9].Fig. 4Continuous tracing shows an episode of paroxysmal AV block of uncertain mechanism in a patient with normal heart and normal ECG. In this patient, AV block occurred without P-P cycle changes, but PR interval was prolonged before block from 0.20 s to 0.28 s in the beat immediately preceding the asystolic pause; furthermore, the asystolic pause was followed by 2:1 AV block with prolonged PR interval up to 0.36 s in the conducted beats. PR prolongation is suggestive of vagal AV block (EI-AVB). Nevertheless, in this patient, AV block occurred without P-P cycle changes, which is suggestive of idiopathic AVB; the low adenosine value of 0.10 μmol/L (normal value: 0.40--0.80 μmol/L) observed in this patient supports this mechanism. AV=atrioventricular; ECG=electrocardiography.Fig. 4.

In brief, the diagnosis is made using ECG findings and clinical and laboratory features reported in [Table 1](#t0005){ref-type="table"} and [Fig. 5](#f0025){ref-type="fig"}.Fig. 5Distinctive features of the three types of paroxysmal AVB AVB=atrioventricular block; BBB= bundle branch block; CSM= carotid sinus massage; TT= tilt testing; SHD= structural heart disease; EPS = electrophysiological study.Fig. 5.

3. Role of electrophysiological study (EPS) and prolonged ECG monitoring in patients with unexplained syncope and BBB {#s0015}
=====================================================================================================================

I-AVB should be considered as a possibility in patients with unexplained syncope and BBB [@bib18]. At follow-up, the rate of development of stable AVB has been seen to increase from 2% in patients with BBB without syncope to 17% in patients with BBB and syncope [@bib21] and up to 37% in those with a positive EPS or those who have undergone prolonged ECG monitoring [@bib22], [@bib23]. Consequently, approximately 50% patients with unexplained syncope and BBB were reported to require cardiac pacing at the end of a standardized evaluation [@bib18], [@bib22], [@bib24].

The diagnostic work-up of patients with unexplained syncope and BBB should start with a few days of ECG monitoring [@bib9]. Early recording improves the diagnostic yield [@bib6] and is justified by the need to avoid immediate risk to the patient [@bib25].

After initial negative (in-hospital) ECG monitoring, EPS is recommended in patients with preserved ejection fraction. EPS is no longer indicated in patients with severely depressed ejection fraction, as in these cases, implantation of an implantable cardioverter defibrillator (ICD) should be indicated irrespective of the mechanism of syncope [@bib9]. The following EPS findings are considered diagnostic: baseline HV interval ≥70 ms and second- or third-degree His-Purkinje block during incremental atrial pacing or after intravenous class IC antiarrhythmic drug challenge [@bib9]. These criteria have an acceptable positive predictive value [@bib23], [@bib26], [@bib27], but low sensitivity: false negative responses have been found in 33--45% patients with syncope, BBB and negative EPS [@bib22], [@bib24]. In other words, a negative EPS cannot rule out the presence of paroxysmal AVB in patients with BBB; further investigations, i.e. implantable loop recorder (ILR), are therefore warranted in case of negative EPS to establish a symptom-rhythm correlation [@bib5], [@bib22], [@bib23], [@bib28]. ILR is able to establish a symptom-rhythm correlation in one out of three patients (the most frequent finding being I-AVB: 63--71% of recorded events) [@bib22], [@bib24].

The decision of whether to perform EPS before ILR implantation depends on the global risk-benefit assessment of an invasive procedure. Although the risk of syncopal recurrence after the index episode is strictly related to the number of syncopes [@bib22], [@bib29], ILR may be useful even after the first episode, as the risk of third-degree AVB block is 10.7% /year in patients with BBB [@bib30].

4. Treatment {#s0020}
============

4.1. Cardiac pacing {#s0025}
-------------------

### 4.1.1. I-AVB {#s0030}

There is general agreement that, in patients with documented I-AVB, cardiac pacing relieves syncopal recurrences and improves survival [@bib9], [@bib31]. In paced patients with documented I-AVB, syncopal recurrences are virtually eliminated, being 1% over 5 years of follow-up [@bib1]. By contrast, in patients paced for unexplained syncope and BBB (AVB still undocumented), the recurrence rate of syncopal events is 7% over 2 years of follow-up [@bib24] when EPS is positive, 13.5--14% over 5 years of follow-up when EPS is not performed [@bib1], [@bib32] and 25--27% over 31 months of follow-up when pacing is administered empirically without EPS or ILR documentation [@bib23], [@bib32].

### 4.1.2. EV-AVB {#s0035}

Cardiac pacing has much lower efficacy in preventing syncopal recurrences in patients affected by EV-AVB even if a spontaneous asystolic reflex has been documented. No studies have specifically investigated the effect of cardiac pacing in patients with EV-AVB. Indeed, all studies on cardiac pacing have involved patients affected by vasovagal syncope, with EV-AVB patients constituting a minority of the population. Therefore, we can only infer that the result of pacing in the EV-AVB subgroup is not different from that of the overall population. In the ISSUE 2, SUP 2, and ISSUE 3 trials [@bib29], [@bib33], [@bib34], dual-chamber cardiac pacing in patients with syncope and documentation of asystolic pause (either sinus arrest or AVB) by means of ECG monitoring was associated with a not infrequent recurrence rate of syncopal events (12--25% at 2-year follow-up). Although cardiac pacing is the most effective therapy when bradycardia is responsible for syncope, syncope may recur because of the coexistence of a vasodepressor reflex, which is present to some degree in virtually all patients. The absence of the above-mentioned \"hypotensive susceptibility,\" as evidenced by a negative tilt test result, has been associated with higher efficacy of pacing in preventing syncopal recurrences, similar to that observed in documented I-AVB [@bib35].

### 4.1.3. EI--AVB {#s0040}

No trial has been performed. Permanent cardiac pacing was successful in preventing syncopal recurrences during long-term follow-up in two small observational cohorts of EI-AVB patients [@bib16], [@bib36].

[Table 2](#t0010){ref-type="table"} summarizes the expected benefit of pacing in patients with different types of AVB.Table 2Expected benefit of pacing in patients with different types of AVB.Table 2**Clinical formsExpected syncope recurrence rate at 2 years follow-up on cardiac pacing**--ECG documented I-AVB--ECG documented EI-AVBHigh efficacy (≤5% recurrence rate)--ECG documented EV-AVB, no hypotensive susceptibilityModerate efficacy (5--20% recurrence rate)--Unexplained syncope and BBB (undocumented AVB; empiric pacing)--ECG documented EV-AVB and hypotensive susceptibilityLow efficacy (\>20% recurrence rate)[^2]

4.2. Theophylline {#s0045}
-----------------

Since patients with low plasma adenosine levels are highly susceptible to exogenous and endogenous adenosine, the effect of treatment with theophylline, a non-selective adenosine receptor antagonist, in the prevention of syncopal recurrences has been investigated. In two recent small observational studies, oral theophylline appeared to be effective over a mean follow-up of 16 and 17 months in patients with an established diagnosis of EI-AVB and may be considered an alternative to permanent pacing in such patients [@bib36], [@bib37].

No studies on the role of theophylline in I-AVB are available.

A few small observational studies on patients with EV-AVB treated with theophylline have recorded a recurrence rate ranging between 12% and 22% [@bib38], [@bib39], [@bib40]. In a randomized controlled trial [@bib41], theophylline proved ineffective in preventing reflex syncope in patients affected by sick sinus syndrome compared with the no-treatment arm.
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[^1]: Abbreviations: AVB=atrioventricular block; ECG=electrocardiography; BBB=bundle branch block; APB=atrial premature beat; VPB=ventricular premature beat

[^2]: Abbreviations: AVB=atrioventricular block; ECG=electrocardiography; I-AVB=intrinsic atrioventricular block; EI-AVB=extrinsic idiopathic atrioventricular block; EV-AVB=extrinsic vagal atrioventricular block; BBB=bundle branch block
